DEMECAN launches medicinal cannabis flower with cultivar Sour Kush
Berlin/Dresden, May 09, 2022 – DEMECAN, the only independent German producer of medicinal cannabis, is celebrating the launch of its supply agreement with Northern Green Canada with the launch of its new indica-dominant medicinal cannabis flower. With the expansion of the product portfolio, DEMECAN is helping to further improve patient care in Germany and is further expanding its position in the German cannabis market.
DEMECAN introduces the first cannabis flower from Northern Green Canada: it is an Indica-dominant cannabis flower with high THC levels and the cultivar Sour Kush (OG Kush x Sour Diesel), a multi-award-winning cross between Sour Diesel strains and OG Kush.
New cannabis flower in “Made in Germany” quality
By concluding the supply agreement with Northern Green Canada Inc., DEMECAN will be able to supply pharmacies and patients with the high-quality cannabis from its EUGMP-certified partner in the future. Cultivation in an indoor facility ensures the highest quality standards, especially in terms of consistent concentrations of active ingredients, rich terpene abundance, and an extremely low microbiological load. This means that radiation is not necessary. In order to ensure a particularly high level of quality, DEMECAN also carries out the final processing in Germany.
Interested doctors and pharmacies can find further information in the specialist area of the DEMECAN website, via DEMECAN customer service or the Medical Affairs Team. Patients can contact their doctor or pharmacy for information.
DEMECAN is the only independent German company that covers the entire value chain for medical cannabis – from cultivation to processing and storage to distribution to pharmacies. The company was founded in 2017 by Dr. Adrian Fischer, Dr. Cornelius Maurer and Dr. Constantin von der Groeben with the aim of guaranteeing patients access to medical cannabis in “Made in Germany” quality. In May 2019, DEMECAN was awarded a state contract by the Federal Institute for Drugs and Medical Devices (BfArM) as the only independent German company to cultivate and distribute medical cannabis in Germany. Cultivation and further processing are carried out according to the highest pharmaceutical standards (EU-GMP) at the company’s facility near Dresden. As a pharmaceutical wholesaler, DEMECAN works with cannabis producers worldwide and imports medical cannabis that meets its own high quality standards. The DEMECAN Group is a member of the Federal Association of Pharmaceutical Cannabinoid Companies (BPC) and a supporting member of the Association of Pharmacies Supplying Cannabis (VCA e.V.).
About Northern Green Canada
Northern Green Canada Inc. is the first privately held EU GMP-certified cannabis producer focused on providing cannabis medicines for a better quality of life. Their experienced team of experts operates in an EU GMP-certified, 2500 m2 (27000 square foot) indoor growing and processing facility with a 4275 m2 (46000 square foot) expansion capability. The company is growing their extraction capacity to produce oils and is working with respected partners on treatment-based cannabis medications.
Find more information at: www.northerngreencanada.com